53-36-1

  • Product Name:Methyl Prednisolone Acetate
  • Molecular Formula:C24H32O6
  • Purity:99%
  • Molecular Weight:416.514
Inquiry

Product Details:

CasNo: 53-36-1

Molecular Formula: C24H32O6

Appearance: Off-White Solid

Chinese Factory Supply Top Purity Methyl Prednisolone Acetate 53-36-1 Cheap Price

  • Molecular Formula:C24H32O6
  • Molecular Weight:416.514
  • Appearance/Colour:Off-White Solid 
  • Vapor Pressure:5.41E-16mmHg at 25°C 
  • Melting Point:206oC 
  • Refractive Index:1.58 
  • Boiling Point:582.5 °C at 760 mmHg 
  • PKA:12.41±0.70(Predicted) 
  • Flash Point:196.5 °C 
  • PSA:100.90000 
  • Density:1.26 g/cm3 
  • LogP:2.37440 

Methylprednisolone acetate(Cas 53-36-1) Usage

Description

Methylprednisolone acetate (MPA) is a synthetic glucocorticoid corticosteroid and a corticosteroid ester, specifically the C21 acetate ester of methylprednisolone. It is widely used in clinical and veterinary medicine for its anti-inflammatory and immunosuppressive properties. Methylprednisolone acetate is sold under various brand names, including Depo-Medrol.

Uses

Methylprednisolone acetate is primarily used to treat pain and inflammation associated with various musculoskeletal disorders, including arthritis. It is also used for the symptomatic relief of dysmenorrhea, a condition characterized by painful menstrual periods. Additionally, it may be used for other conditions as determined by a healthcare provider.

Brand name

Methylprednisolone acetate is available under various brand names, with Depo-Medrol being one of the most commonly recognized brands.

InChI:InChI=1/C24H32O6/c1-13-9-16-17-6-8-24(29,20(28)12-30-14(2)25)23(17,4)11-19(27)21(16)22(3)7-5-15(26)10-18(13)22/h5,7,10,13,16-17,19,21,27,29H,6,8-9,11-12H2,1-4H3

53-36-1 Relevant articles

Formulation and Evaluation of Pharmaceutically Equivalent Parenteral Depot Suspension of Methyl Prednisolone Acetate

A. Alam, MD., Alka Ahuja, Sanjula Baboota, S. K. Gidwani,1 and J. Ali*

, Indian J Pharm Sci. 2009 Jan-Feb; 71(1): 30–34.

For the analysis of methyl prednisolone acetate by HPTLC, pre- coated silica gel 60 F (254) plates (E. Merck India, Ltd.) were selected Formic acid, ethyl acetate, toluene, methanol, acetonitrile, diethyl ether were used separately as neat solvents. Developed chromatograms were then visualized in iodine chamber for the detection of methyl prednisolone acetate spots.

Dangers From Methylprednisolone Acetate Therapy by Intraspinal Injection

Dewey A. Nelson, MD

, Archives of neurology, 1988

Clinical trials first began in 1960 with methylprednisolone acetate (Depo-Medrol) administered intrathecally, in an attempt to treat both disk disease and multiple sclerosis. After a few reports of salubrious results, there began an out-pouring of contradictory data, which continues in 1988.

Intra-articular steroids in knee osteoarthritis: a comparative study of triamcinolone hexacetonide and methylprednisolone acetate

Debasish Pyne, Yiannakis Ioannou, Ramesh Mootoo & Asgar Bhanji

, Clinical Rheumatology, Volume 23, pages 116–120, (2004)

The aim of this study was to compare the effectiveness of triamcinolone hexacetonide (THA) and methylprednisolone acetate (MPA), given via the intra-articular route at equipotent dosage to patients with symptomatic knee OA with effusion, in a double-blind randomized comparative trial.

53-36-1 Downstream products

  • 83-43-2
    83-43-2

    Methylprednisolone

  • 86401-94-7
    86401-94-7

    17α-acetoxy-11β,21-dihydroxy-6α-methyl-1,4-pregnadiene-3,20-dione

  • 6870-94-6
    6870-94-6

    11β,17α-dihydroxy-6α-methyl-1,4-pregnadiene-3,20-dione

  • 61919-52-6
    61919-52-6

    11β-hydroxy-6α-methyl-1,4-androstadiene-3,17-dione

Relevant Products